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Abstract 
Background: This study aimed to estimate the socio‑economic costs of uncomplicated malaria and to explore 
health care‑seeking behaviours that are likely to influence these costs in the Democratic Republic of Congo (DRC), a 
country ranked worldwide as the second most affected by malaria.
Methods: In 2017, a cross‑sectional survey included patients with uncomplicated malaria in 64 healthcare facilities 
from 10 sentinel sites of the National Malaria Control Programme (NMCP) in the DRC. A standard questionnaire was 
used to assess health care‑seeking behaviours of patients. Health‑related quality of life (HRQL) and disutility weights 
(DW) of illness were evaluated by using the EuroQol Group’s descriptive system (EQ‑5D‑3L) and its visual analogue 
scale (EQ VAS). Malaria costs were estimated from a patient’s perspective. Probabilistic sensitivity analyses (PSA) evalu‑
ated the uncertainty around the cost estimates. Generalized regression models were fitted to assess the effect of 
potential predictive factors on the time lost and the DW during illness.
Results: In total, 1080 patients (age: 13.1 ± 14 years; M/F ratio: 1.1) were included. The average total costs amounted 
to US$ 36.3 [95% CI 35.5–37.2] per malaria episode, including US$ 16.7 [95% CI 16.3–17.1] as direct costs and US$ 19.6 
[95% CI 18.9–20.3] indirect costs. During care seeking, economically active patients and their relatives lost respectively 
3.3 ± 1.8 and 3.4 ± 2.1 working days. This time loss occurred mostly at the pre‑hospital stage and was the parameter 
associated the most with the uncertainty around malaria cost estimates. Patients self‑rated an average 0.36 ± 0.2 DW 
and an average 0.62 ± 0.3 EQ‑5D index score per episode. A lack of health insurance coverage (896 out of 1080; 82.9%) 
incurred substantially higher costs, lower quality of life, and heavier DW while leading to longer time lost during ill‑
ness. Residing in rural areas incurred a disproportionally higher socioeconomic burden of uncomplicated malaria with 
longer time lost due to illness and limited access to health insurance mechanisms.
Conclusion: Uncomplicated malaria is associated with high economic costs of care in the DRC. Efforts to reduce the 
cost‑of‑illness should target time lost at the pre‑hospital stage and social disparities in the population, while reinforc‑
ing measures for malaria control in the country.
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Background
Malaria remains a major public health concern with its 
highest burden occurring in Africa, where more than 
200 million cases are reported yearly [1]. Beside its 
high morbidity and mortality in the continent, malaria 
diverts substantial financial resources from individuals 
and countries towards prevention and treatment efforts 
[2, 3]. Consequently, the malaria burden weighs heav-
ily on households, the healthcare system, and economic 
growth and development [3–5]. While affecting the 
health and wealth of nations, malaria is both a disease of 
poverty and a cause of poverty in endemic countries [5]. 
This is particularly the case in the Democratic Republic 
of Congo (DRC), which accounts for a tenth of the bur-
den of malaria in Africa with over 15  million cases and 
25 thousand deaths recorded every year [1, 6, 7]. Nearly 
all its population lives in high transmission zones where 
malaria is caused mainly by Plasmodium falciparum, the 
deadliest species linked to severe complications espe-
cially in children under five [6, 7].
The DRC is the largest and most populated country 
in Middle Africa, with an estimated 89  million inhabit-
ants living mostly in rural areas (61.6%) [8]. With a Gross 
Domestic Product (GDP) of US$  514/year/inhabitant 
in 2017, the DRC is among the countries with the low-
est income worldwide (https:// tradi ngeco nomics. com/ 
congo/ indic ators; accessed on 12 March 2020). Total 
expenditure on health in the country is low (e.g., only 
US$  13 per capita per year in 2012) with households 
being the largest contributors, closely followed by multi-
lateral aid, while the central government contributes only 
11% [9]. The health system in the country is organized 
in a pyramidal structure with three levels: the National 
Ministry of Public Health (i.e., central level), provincial 
health departments (i.e., intermediate level), and health 
districts (i.e., peripheral level) [9, 10]. To specifically 
reduce the burden of malaria in the country, a National 
Malaria Control Programme (NMCP) was implemented 
within the national health system in the 2000s and relies 
mainly on external funding for its activities [7]. The 
most up-to-date anti-malarial policies that are outlined 
in the National Malaria Control Strategic Plan (NSP) 
2016–2020 recommend free universal access to malaria 
prevention, diagnosis, and treatment services in different 
health facilities [11, 12]. All health districts and respec-
tive provincial health departments currently integrate 
the national anti-malarial policy and thus connect to 
the NMCP. Subsequent to the deployment of national 
policies, significant progress in terms of the country cov-
erage by malaria control services and reduced cases was 
noted in 2010–2015 [7].
However, despite the NMCP’s efforts, patients with 
malaria still face several barriers to accessing health 
services, including economic costs resulting from lost 
productivity due to the impact of illness or incurred to 
afford care during the infection episode [8, 13]. With 
less than 10% of the population covered by formal health 
insurance programmes, the national health system relies 
heavily on households’ direct contributions even for 
diseases, such as malaria that receive substantial mul-
tilateral aid [9, 10]. Patients can thus be deterred from 
utilizing malaria health care by high care costs that may 
drive the use of less effective care or practices [10, 14]. 
This situation leads to equity issues between regions that 
impact the quality of life of populations [9, 15]. Ascer-
taining costs of malaria care and associated factors can 
provide essential information for soliciting appropriate 
funding for its control, from both government and non-
government organizations, to reduce any out-of-pocket 
expenditure in the population. Moreover, identifying key 
factors that affect health care costs would be critical for 
decision-making, priority setting, and resource allocation 
[9, 16]. The country’s income, geographic location, and 
health care strategies have thus been widely described 
as factors that influence the economic costs of malaria 
at the population scale [16]. At the level of individuals, 
health care-seeking behaviours (e.g., self-medication, 
delayed behaviours) linked to personal beliefs and health 
awareness have been reported to influence the cost-of-
illness [17–19]. The clinical form of malaria—i.e., severe 
or uncomplicated malaria—may also substantially affect 
the disease burden in endemic regions. In fact, unlike the 
severe form of malaria that is limited to specific groups 
at high risk (e.g., children under five years, pregnant 
women, immunocompromised patients), uncomplicated 
malaria exhibits an excellent prognosis within 48 to 72 h 
after early diagnosis and prompt initiation of an effective 
treatment [20, 21]. However, this clinical form of malaria 
may account for the highest burden due to its high 
incidence and the occurrence of multiple intermittent 
episodes in the same individuals over the time [21]. How-
ever, in DRC, only limited studies have been conducted 
to assess the costs of malaria, focusing mainly on severe 
malaria and on malaria episodes at small scales (e.g., sin-
gle hospital or single city) [14, 15, 22, 23]. Therefore, this 
study aimed to estimate the socioeconomic burden of 
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uncomplicated malaria across the DRC while exploring 




In the DRC, the peripheral level of the health system 
comprises 516 health districts, where a district team 
manages a network of health centres and a district hospi-
tal typically covering a population of 100,000 to 200,000 
[9, 10]. At the intermediate level, a provincial health 
department is responsible for technical and logistical 
support of health services in each of the country’s 26 
provinces. A coordination or a direction integrated in 
the National Ministry of Public Health has a normative 
role and constitutes the central level of the health system 
[9, 10]. Health districts are classified as rural or urban 
based on their geographical location. Compared to urban 
districts, rural areas are characterized by more poverty, 
private for-profit health care service delivery points, less 
qualified health personnel, inefficient workforce deploy-
ment, difficulties in transportation, and insufficient social 
services, but also less promiscuity [9]. Healthcare facili-
ties are central to the provision of malaria treatment and 
hence critical to the success of its management in the 
country [11]. The recommended drugs for uncomplicated 
malaria are a combination of artesunate + amodiaquine 
(ASAQ) or that of artemether + lumefantrine (AL) [12]. 
The NMCP manages malaria activities in each health dis-
trict and routinely monitors the efficacy of malaria con-
trol strategies through a network of sentinel sites set in 
26 selected health districts [10, 12]. This study was car-
ried out in ten of these NMCP sentinel sites to capture 
the cost-of-illness in both urban and rural conditions 
during uncomplicated malaria.
Study participants
This study targeted patients with uncomplicated malaria 
who sought care and received treatment at health facili-
ties in selected sites. An uncomplicated malaria case was 
defined as any symptomatic patient with a diagnosis of 
malaria confirmed by microscopy or rapid diagnostic 
test, whose clinical status did not require hospitalization. 
Patients with known co-morbidities (i.e., other diagnosed 
chronic or acute illness) or documented pregnancy were 
excluded from the study to allow, as far as possible, a spe-
cific evaluation of the impact of malaria on patients’ qual-
ity of life.
Study design and data collection
A cross-sectional survey was conducted from January 
to December 2017 in 10 of the 26 NMCP sentinel sites, 
selected based on their accessibility and functionality 
for malaria surveillance activities. Three of these sites 
were located in urban areas (Kinshasa, Lubumbashi, and 
Kisangani) and seven in rural areas (Vanga, Bolenge, 
Karawa, Kalima, Fungurume, Kamina, and Katana) 
(Fig.  1). In total 64 healthcare facilities were involved 
in the data collection. At each collection site, the field 
research team consisted of the head nurse in charge of 
malaria activities for each corresponding health dis-
trict, a general practitioner, a nurse, and a laboratory 
technician recruited from a local healthcare facility. All 
teams were initially trained to conduct interviews using 
study questionnaires [See Additional file  1]. Before-
hand, the questionnaires were pre-tested and translated 
into national languages spoken in the different sites 
(i.e., French, Lingala, Kikongo, and Kiswahili) and back-
translated to English. The data collected included socio-
economic characteristics, general knowledge on malaria, 
malaria-related attitudes and practices at the household 
level, information about previous and current malaria 
episodes with details about the trajectory followed dur-
ing the care-seeking, as well as expenditures and time 
lost due to the current malaria episode. In addition, the 
health-related quality of life (HRQL) was assessed for 
each patient on arrival at the healthcare facility using 
the EuroQol Group’s descriptive system (EQ-5D-3L) and 
its visual analogue scale (EQ VAS) [24, 25]. An associ-
ated investigator reviewed the collected data daily and 
supervised research teams on the field. Data were dou-
ble entered, cross-checked, and corrected in an Excel 
spreadsheet.
Estimation of economic costs
Total economic costs of uncomplicated malaria episodes 
in DRC were estimated for the year 2017 in two steps. 
First, case-based parameters (i.e., cost parameters or unit 
costs) were obtained through the field survey follow-
ing a bottom-up approach measuring health cost inputs 
from the patient’s perspective. A “bottom-up” approach 
estimates total costs for specific health care services by 
relying on expense inputs recorded at the level of individ-
uals, rather than aggregated data at population level that 
would be required for a “top-down” method [26]. Costs 
from the “patient’s perspective” are defined as expenses 
estimated according to  the patients, their  experience 
of health care services, and self-perceived impact of the 
health condition on their life, as well as their expectations 
of the consultation or the caregivers, and their priorities 
regarding the outcomes of treatment [27]. Two catego-
ries of input were used for estimating total average costs, 
including direct and indirect costs of care for uncom-
plicated malaria [26, 27]. In the second step, total costs 
for the country were estimated by extrapolating average 
costs to all malaria episodes recorded across the country 
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by the NMCP in 2017. Unit costs initially obtained in 
Congolese Francs (CDF) were converted to United States 
Dollars (US$) using the average exchange rate in 2017 
(one US$ = CDF 1648).
Direct costs
Direct costs were defined as out-of-pocket health 
expenditures  paid by a patient and his/her relatives 
for medical products and services (i.e., direct medical 
costs) used to detect and treat the malaria episode, as 
well as costs for non-medical services (i.e., direct non-
medical costs) that are the result of illness [26, 27]. 
Resources for these out-of-pocket expenditures were 
sought at both the pre-hospital stage (i.e., outside the 
circuit of formal health establishments and before 
undertaking a medical consultation) and the hospi-
tal stage (i.e., after the medical consultation). Costs 
incurred at the hospital stage included fees for the 
medical consultation, laboratory analyses (diagnosis by 
RDTs and other biological tests), treatment (i.e., anti-
malarial drugs, antipyretics, analgesics, vitamins, and 
care administration), and follow-up. Follow-up costs 
included costs of a second medical consultation and a 
microscopic examination scheduled three days after the 
start of anti-malarial treatment according to national 
malaria treatment guidelines. Direct non-medical 
costs investigated in this study included transportation 
costs for a patient and his/her relatives, and other costs 
resulting from the illness (including telephone calls, 
food consumed during the care-seeking process).
Fig. 1 Geographic map of sampling sites in Democratic Republic of Congo. This map displays each site where the survey took place. Unshaded 
regions represent provinces from which no sample was collected during this study while regions shaded in gray represent surveyed provinces. 
Circles represent the sample size of patients included in each NMCP sentinel site selected for the survey, with orange circles being located in urban 
areas and aqua circles in rural areas
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Indirect costs
Indirect costs of malaria were defined as potential losses 
of productivity or work income that economically active 
(EA) individuals incurred due to illness [26]. Therefore, 
cost estimation multiplied the reported time lost from 
work in days (cost parameter expressed in person-days) 
by the amount of money lost in 1  day for not working 
(person-day unit cost). Person-day unit costs (US$  5.0) 
for patients, relatives, and eventual substitutes in the 
workplace were calculated using the monthly minimum 
wage of 2017 as reference, by dividing it by the number of 
working days per month (http:// www. fec- rdc. com/ index. 
php/ nos- publi catio ns/ categ ory; accessed on 15 Decem-
ber 2019). EA individuals were defined as those who 
were ≥ 15  years old (i.e., the economically active sub-
population) [28]. Time losses included in the cost esti-
mation were obtained by interrogating the waiting time 
while undertaking health care, days off from daily activi-
ties (school or work) due to illness (in the patient’s case) 
or due to the need to support a patient’s care (in the case 
of the patient’s relatives).
Average cost per episode and total costs
The direct and indirect costs obtained from the patient’s 
perspective yielded the average total cost per epi-
sode. Costs of all malaria episodes per patient during 
one year were achieved by multiplying the average total 
costs by the number of reported putative malaria epi-
sodes in a year. The total costs for the country in 2017 
were obtained by multiplying average total costs by the 
number of malaria episodes recorded in the database of 
the National Health Information System (SNIS) of the 
NMCP for that year.
Evaluation of the quality of life and disutility weight 
during malaria episodes
The health-related quality of life (HRQL) during uncom-
plicated malaria was evaluated using a EQ-5D toolkit 
developed by the  EuroQol Group [24, 25]. This toolkit 
comprises a three-level version of the EQ-5D system (EQ-
5D-3L) and a visual analogue scale (EQ VAS) that allows 
health outcomes to be measured based on the patient’s 
own judgment [29]. The EQ-5D-3L is a descriptive sys-
tem that classifies health status into three levels (i.e., 
no problems, some problems, and extreme problems) 
across each of its five dimensions: mobility, self-care, 
usual activities, pain/discomfort, and anxiety/depression. 
EQ-5D-3L health states were then converted into index 
“utility” scores using the algorithm established based on 
societal preference values defined for the Zimbabwean 
population [30]. Currently, in Africa the Zimbabwean 
algorithm is the only one that is available for converting 
the EQ-5D-3L questionnaire into a single EQ-5D index 
score. The formula DW = 1–(VAS score/100) was used 
to estimate the disutility weight (DW) on the basis of the 
patient’s self-rated EQ VAS visual scale with endpoints 
from 100 “best imaginable health state” to 0 “worst imag-
inable health state” [31].
Data analysis
Data analysis was carried out using R software version 
3.5.3 (The R Development Core Team, R Foundation for 
Statistical Computing, Vienna, Austria, 2019). Absolute 
and relative frequencies were used to summarize quali-
tative variables. Averages with corresponding standard 
deviations (SD) were used to describe quantitative char-
acteristics of patients, while means with standard errors 
(SE) described the deviation inferred on the population. 
When appropriate, qualitative variables were compared 
between groups using the Chi-square test or the Fisher 
exact test. In contrast, quantitative variables were com-
pared using parametric (e.g., ANOVA test or t-test) or 
non-parametric tests (Kruskal–Wallis rank sum test or 
Wilcoxon rank sum test with continuity correction), the 
normality and homogeneity of variances in distributions 
being tested with the Shapiro–Wilk test and the Lev-
ene test. Moreover, uni- and multivariable generalized 
linear models (GLMs) were fitted to assess the effect of 
potential predictive factors on the time lost and the DW 
during uncomplicated malaria. A Gamma distribution 
and a Beta distribution with a log-link function were 
respectively assumed to model the time lost and the DW. 
Whenever a multivariable model was considered, the 
final model was selected based on Akaike’s “An Infor-
mation Criterion”  (AIC) values calculated for GLMs in 
a stepwise algorithm using both backward and forward 
directions. A significance level of p < 0.05 was considered 
for all statistical tests.
Multi-way probabilistic sensitivity analysis (PSA) 
assessed the confidence of estimated average costs per 
uncomplicated malaria episode in DRC (total costs for 
the country in 2017 divided by the total number of epi-
sodes). This took into account the uncertainty that sur-
rounded the most relevant base case parameters (i.e., 
point estimates for cost parameters and unit costs 
obtained in the survey) by defining probability distri-
butions for them as described elsewhere [32]. The beta 
distribution was chosen for the probability of being eco-
nomically active either among malaria patients or rela-
tives; while the gamma distribution was used for unit 
costs (e.g., unit costs related to malaria diagnosis and 
treatment) and the time lost from work due to a malaria 
episode. Then, 10,000 Monte Carlo simulations were 
conducted to propagate uncertainty by sampling values 
from all the probability distributions jointly and calcu-
lating the corresponding values for the cost per malaria 
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episode. Finally, upper and lower 95% uncertainty lim-
its (2.5 and 97.5%) for the cost per malaria episode were 
obtained from these simulations and reported using tor-
nado diagrams.
Results
Socio‑economic characteristics of patients 
with uncomplicated malaria in the DRC
Overall, 1080 malaria patients (age: 13.1 ± 14.0  years; 
ratio M:F = 1.1), mostly living in rural areas (n = 688; 
63.7%), were enrolled in 64 healthcare facilities, from 
the 10 selected NMCP sentinel sites (Table  1). There 
was no difference in gender (p = 0.509) and education 
level (p = 0.163) between patients from rural and urban 
areas. Patients from rural areas were older (average age: 
14.9 ± 14.9; p < 0.001), less covered by a health care insur-
ance (4.7%; p < 0.001), more frequently among the most 
economically disadvantaged patients (163 of 219 patients 
of the poorest quintile; p < 0.001), and more likely to 
be treated in a private for-profit health facility (62.9%; 
p < 0.001) than those from urban areas. The proportion 
of malaria patients holding health insurance policies was 
significantly lower in female subjects than males (14.3% 
and 19.9%; p = 0.017), in adult than young patients (12.5% 
and 19.2%; p = 0.008), and in those with the lowest edu-
cation level than the most educated ones (0.0% and > 13%; 
p < 0.02). In addition, substantially fewer health insur-
ance holders were observed among patients from rural 
areas than those from urban settings (4.7% and 38.8%; 
p < 0.001), among those from the most economically dis-
advantaged category than others (only 0.2% and > 12%; 
p < 0.001), and in those seeking care in private for-profit 
healthcare facilities than in conventional ones (11.6% and 
25.9%; p < 0.001) [See Additional file 2].
Malaria knowledge, attitude, and practices of malaria 
patients in the DRC
Although most respondents knew the main mecha-
nism of malaria transmission (mosquito bite: 83.1%), 
there were people who were still unaware of this mecha-
nism (7.1%) or were still evoking inappropriate mecha-
nisms (11.5%), including: non-potable drinking water, 
Table 1 Baseline socio‑economical characteristics of patients with uncomplicated malaria in the DRC
a Average ages of patients in rural and urban areas were 14.9 ± 14.9 and 11.0 ± 12.1 years old, respectively (p < 0.001)
Characteristics Rural area Urban area Total p‑value
n = 688 n = 392 n = 1080
n % n % n %
Gender 0.509
 Female 358 52 195 49.7 553 51.2
 Male 330 48 197 50.3 527 48.8
Education level (n = 257; age ≥ 18 years) 0.163
 No education 31 14.6 7 9.3 38 13.2
 Primary level 36 17 8 10.7 44 15.3
 High school level 117 55.2 44 58.7 161 56.1
 College or University level 28 13.2 16 21.3 44 15.3
Age group (years)a  < 0.001
 [0–5] 244 35.5 146 37.2 390 36.1
 [5–15] 187 27.2 152 38.8 339 31.4
  ≥ 15 257 37.4 94 24 351 32.5
Socio‑economic index quintile  < 0.001
 Quintile 1 "most economically disadvantaged" 163 23.7 56 14.3 219 20.3
 Quintile 2 "very economically disadvantaged" 94 13.7 125 31.9 219 20.3
 Quintile 3 "economically disadvantaged" 151 21.9 65 16.6 216 20
 Quintile 4 "less economically disadvantaged" 151 21.9 68 17.3 219 20.3
 Quintile 5 "least economically disadvantaged" 129 18.8 78 19.9 207 19.2
Health insurance status  < 0.001
 Yes 32 4.7 152 38.8 184 17.1
 No 656 95.3 240 61.2 896 82.9
Type of healthcare facility  < 0.001
 Conventional 255 37.1 192 49.0 447 41.4
 Private for‑profit 433 62.9 200 51.0 633 58.6
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witchcraft, lack of hygiene and sanitation, contaminated 
food, and bites from various insects. Fever (84.9%), head-
ache (0.3%), chills (33.8%), and generalized pain (22.3%) 
were the most common malaria symptoms identified by 
respondents. Mosquito bed nets were evoked as the most 
effective method for malaria prevention (84.4%). How-
ever, 7.3% of respondents were still convinced that there 
is no effective prevention method, while 1.1% of them 
were still unaware of any existing prevention approach. 
Overall, respondents from rural areas had better knowl-
edge of malaria transmission mechanisms and prevention 
methods (p < 0.001) [See Additional file 3]. Mosquito bed 
nets were available in most of respondents’ households 
(about 90%) and had been acquired mostly during the 
past three years (in around 95%) [See Additional file 4]. 
However, only 76.7% of patients (81.7% among children 
under 5 years old) reported having slept under a bed net 
the night before the survey.
Health care‑seeking behaviour during malaria episodes 
in the DRC
More than half of the patients (57.8%) had at least one 
malaria episode in the past year besides the episode diag-
nosed at the time of the survey. The average number of 
malaria episodes per participant reported by patients 
in a year was 2.7 ± 1.6. The most recent malaria episode 
reported by participants dated back 3.7 ± 2.7  months 
before the survey, but 19.0% of them were not tested 
for malaria and 6.7% did not take any anti-malarial 
drug. During the episode diagnosed at the time of the 
survey, patients lost 3.3 ± 1.8  days, which represented 
about half of the total duration of illness (~ six days) and 
occurred mainly at the pre-hospital stage. Upon arrival 
in hospitals, the majority of patients (68.7%) had already 
attempted to treat their illness. Treatment at pre-hospital 
stage mainly came from the informal sector (~ 72% of 
cases), including an anti-malarial drug in nearly one out 
of four cases (26.3%) [See Additional file 5].
Social burden and quality of life during uncomplicated 
malaria illness in the DRC
More than half of the patients (> 50%) with uncompli-
cated malaria episodes reported moderate to extreme 
problems in different dimensions of HRQL defined by 
the EQ-5D-3L questionnaire. These problems were more 
frequent in urban than in rural areas during malaria 
episodes, especially in dimensions related to self-care, 
usual activity, and anxiety or depression (p < 0.001) [See 
Additional file  6]. Malaria patients reported an average 
0.36 ± 0.2 DW on the EQ VAS and an average 0.62 ± 0.3 
EQ-5D index score. Generalized linear models predicted 
a significantly increased DW in patients with no health 
insurance coverage (p = 0.005) while average EQ-5D 
index scores were significantly lower in young patients 
(p < 0.001), in those not covered by health insurance 
(p < 0.001), and those residing in rural areas (p < 0.009) 
(Tables 2,  3). 
Each malaria episode caused 1.2 ± 1.1 individu-
als (including patients and relatives) to be absent from 
social activities. Of 351 patients (32% of total patients) 
who were economically active (EA, > 15  years old), 239 
(68%) were absent from daily activities (i.e., school or 
work) due to their illness. In addition, family members of 
918 patients (85% of all patients) had to interrupt their 
economic activities due to patients’ requirements for 
malaria care. One malaria episode caused an average loss 
of 3.1 ± 2.2  days among EA patients and 3.4 ± 2.1  days 
among EA relatives [See Additional file 5]. The multivari-
able generalized linear model predicted that the accumu-
lated time lost by EA patients increased substantially in 
patients residing in rural areas (p < 0.001), in those not 
covered by health insurance (p = 0.049), and those with 
an increased DW (p < 0.001) (Table 4).
Economic costs for uncomplicated malaria episodes 
in the DRC
The total costs associated with 1080 uncomplicated 
malaria episodes in our survey were US$  39,204: 
US$  18,025 (46.0%) corresponded to direct costs and 
US$  21,125 (54.0%) to indirect costs (Table  5). Average 
costs amounted to US$ 36.3 per episode, with US$ 16.7 
being direct costs and US$ 19.6 indirect costs. As patients 
experienced 2.7 malaria episodes per year, the yearly cost 
of malaria was estimated at an average of US$  98 per 
person. Indirect costs associated to the time losses due 
to malaria in patients (US$ 15,707) were higher than the 
costs for their relatives (US $5,409) while treatment costs 
(US$  6,296) and follow-up costs (US$  7,096) accounted 
for most of the direct costs [See Additional files 7 and 
8]. The total economic costs for the DRC nationally were 
estimated to be US$ 503,837,635, with an uncertainty 
interval from US$ 492,664,040 to US$ 515,094,408 [Addi-
tional file 9].
The multi-way PSA, considering the total number of 
uncomplicated malaria episodes in DRC and account-
ing for the uncertainty of all relevant cost parameters at 
the same time, found that the uncertainty limits (2.5% 
and 97.5%) for the average cost per malaria episode were 
between US$ 35.5 and US$ 37.2 [See Additional file 9].
Assessing the uncertainty of individual cost param-
eters (one-way PSA) showed that the time lost due to 
malaria induced most of the uncertainty in the aver-
age cost per malaria episode, with uncertainty intervals 
between US$ 35.9 and US$ 36.6 when accounting for the 
time losses for EA patients, and US$ 35.6 and US$ 36.8 
for the time losses for patients’ EA relatives (second and 
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Table 2 Comparison of EQ‑5D index score in different categories of patients with uncomplicated malaria in the DRC
SD, standard deviation;
Variable n Average (SD) p‑value
All patients 1080 0.62 (0.26) –
Age group
 Adult patients 351 0.65 (0.25)  < 0.001
 Young patients 729 0.61 (0.27)
Health insurance coverage
 Yes 184 0.71 (0.16)  < 0.001
 No 896 0.61 (0.27)
Type of healthcare facility
 Conventional 447 0.6 (0.3) 0.144
 Private for‑profit 633 0.65 (0.23)
Residence
 Rural area 688 0.62 (0.23) 0.009
 Urban area 392 0.63 (0.27)
Socioeconomic index quintile
 Quintile 1 "most economically disadvantaged" 219 0.62 (0.26) 0.222
 Quintile 2 "very economically disadvantaged" 219 0.62 (0.25)
 Quintile 3 "economically disadvantaged" 216 0.61 (0.28)
 Quintile 4 "less economically disadvantaged" 219 0.62 (0.25)
 Quintile 5 "least economically disadvantaged" 207 0.65 (0.26)
Gender
 Female 553 0.63 (0.27) 0.451
 Male 527 0.62 (0.25)
Table 3 Beta generalized linear regression model for the disutility weight (DW) during uncomplicated malaria in the DRC
95% CI, 95% confidence interval; SD, standard deviation; MR: mean ratio
Patients n Average (SD) MR [95% CI] p‑value
Gender
 Male 527 0.36 (0.20) Ref –
 Female 553 0.37 (0.20) 1.0 [0.9; 1.1] 0.654
Age (years) 1080 0.36 (0.20) 0.9 [0.9; 1.0] 0.211
Residence
 Rural area 688 0.36 (0.20) Ref –
 Urban area 392 0.37 (0.21) 1.1 [0.9; 1.1] 0.126
Health insurance coverage
 Yes 184 0.32 (0.18) Ref –
 No 896 0.37 (0.20) 1.2 [1.0; 1.3] 0.005
Socioeconomic index quintile
 Quintile 1 "most economically disadvantaged" 219 0.35 (0.19) Ref –
 Quintile 2 "very economically disadvantaged" 219 0.36 (0.20) 1.1 [0.9; 1.2] 0.389
  Quintile 3 "economically disadvantaged" 216 0.37 (0.20) 1.1 [0.9; 1.2] 0.118
 Quintile 4 "less economically disadvantaged" 219 0.38 (0.21) 1.1 [1.0; 1.3] 0.019
 Quintile 5 "least economically disadvantaged" 207 0.36 (0.20) 1.0 [0.9; 1.2] 0.673
Type of healthcare facility
 Conventional 447 0.36 (0.20) Ref –
 Private for‑profit 633 0.37 (0.20) 1.1 [0.9; 1.1] 0.117
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third coloured bars in Fig. 2). Uncertainty intervals were 
narrower with the initial consultation cost, treatment 
cost, residence area, treatment attempts at pre-hospital 
stage, and diagnosis cost (fourth to eighth bars in Fig. 2). 
The type of healthcare facility was the least influential 
parameter.
Discussion
This study evaluated the socio-economic burden of 
uncomplicated malaria illness in the DRC, the second 
most-affected country in the world. Estimated total 
costs for the 13,863,021 uncomplicated malaria episodes 
registered by the NMCP in the country in 2017 were 
Table 4 Generalized linear regression model for time losses in economically active individuals (≥ 15 years old) with uncomplicated 
malaria in the DRC
95% CI, 95% confidence interval; SD, standard deviation; MR, mean ratio
Variable n Average time (SD) Univariate model Multivariable final model
MR [95% CI] p‑value MR [95%CI] p‑value
Gender
 Male 143 3.6 (2.7) Ref –
 Female 208 3.8 (2.9) 1.1 [0.9; 1.2] 0.494 –
Age (years) 351 3.7 (4.9) 1.0 [1.0; 1.0] 0.105 1.0 [1.0; 1.0] 0.237
Residence
 Urban area 94 4.1 (1.8) Ref Ref
 Rural area 257 2.6 (3.2) 1.6 [1.3; 1.8]  < 0.001 1.5 [1.3; 1.8]  < 0.001
Health insurance coverage
 Yes 44 2.6 (1.9) Ref Ref
 No 307 3.9 (2.9) 1.5 [1.2; 1.9] 0.001 1.2 [1.0; 1.6] 0.049
Socioeconomic index quintile
 Quintile 1 "most economically disadvantaged" 55 3.9 (2.9) Ref –
 Quintile 2 "very economically disadvantaged" 46 4.1 (3.0) 1.0 [0.8; 1.4] 0.787 –
 Quintile 3 "economically disadvantaged" 70 4.2 (3.1) 1.1 [0.8; 1.4] 0.613 –
 Quintile 4 "less economically disadvantaged" 82 3.8 (2.8) 0.9 [0.8; 1.3] 0.844 –
 Quintile 5 "least economically disadvantaged" 98 3.1 (2.3) 0.8 [0.6; 0. 9] 0.045 –
Type of healthcare facility
 Private for‑profit 219 3.7 (2.8) Ref –
 Conventional 132 3.8 (2.9) 1.0 [0.9; 1.2] 0.678 –
Disutility weight 351 3.7 (4.9) 2.8 [1.9; 4.3]  < 0.001 3.0 [2.0; 4.5]  < 0.001
Table 5 Total economic costs associated with uncomplicated malaria from the patient’s perspective, estimated from the survey in the 
DRC
Cost category n Total costs (US$) Cost per episode (US$) SD
Cost for all participants
 Total costs 1080 39,204 36.3 19.1
 Direct costs 1080 18,025.2 16.7 11.8
 Indirect costs 1080 21,124.8 19.6 12.8
Total costs by age
 Adult patients 351 14,067.1 40.1 20.2
 Young patients 729 25,136.5 34.4 18.3
Total costs by area
 Rural areas 688 25,359.3 36.9 18.6
 Urban areas 392 13,844.2 35.3 19.8
Total costs by facility
 Conventional healthcare facility 447 16,795.4 37.6 21.2
 Private for‑profit healthcare facility 633 22,408.1 35.4 17.3
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US$  503,837,635, representing about 6% of the coun-
try’s Gross Domestic Product (GDP) for that year. Aver-
age costs per episode were US$  36.3 (varying between 
US$  35.5 and US$  37.1), being almost 7 times higher 
than the national daily minimum wage. Consistent with 
observations in other endemic areas [4, 33–35], uncom-
plicated malaria leads to substantial exhaustion of fam-
ily assets and loss of income, and may be an important 
cause of poverty in DRC. Overall, cost estimates showed 
limited variability. Several factors may contribute to this 
homogeneity of responses across uncomplicated malaria 
episodes. It could be the result of the narrow fringe of 
clinical alterations sustaining uncomplicated malaria, 
in comparison to severe malaria forms which are more 
heterogeneous in the level of severity and variability of 
symptoms [14]. It may also be a reflection of the regula-
tory efforts from the national anti-malarial policy.
More than half of the costs (54.5%) resulted from indi-
rect costs incurred by economically active patients and 
related family members that were pushed to interrupt 
their daily activities to seek care (~ US$  20 per episode 
based on minimum wage). Of 351 economically active 
patients (EA, > 15 years old), 239 (68%) halted their daily 
activities (i.e., school or work) due to illness, and of all 
patients, 918 (85%) had family members who interrupted 
their economic activities due to requirements for malaria 
care. In fact, one malaria episode led to a loss of about 
three days for economically active patients (equivalent to 
average US$  15.4) and a loss of an additional three and 
a half days (equivalent to average US$ 17.1) accumulated 
in families by the patient’s relatives. Thus, as already 
reported in other African countries, a patient’s uncom-
plicated malaria putatively drives their whole family to 
productivity losses due to absenteeism from daily activi-
ties [15, 36, 37]. Considering the recurrence of malaria 
episodes in each participant (~ 3 per year) suggests the 
extent to which malaria contributes to the impoverish-
ment of families in the DRC. Poverty, in turn, has the 
potential for generating and maintaining conditions per-
petuating malaria transmission in the population [3–5, 
16, 36]. Therefore, important efforts in terms of health 
care policies and socio-economic measures need to be 
implemented to break the vicious cycle between poverty 
and malaria that threatens the population in DRC.
The length of time lost due to illness in the current 
study occurred mainly at the pre-hospital stage, and 
this turned out to be the parameter that had the great-
est influence on the average costs per malaria episode in 
DRC. This is understandable since consistent observa-
tions on patients with uncomplicated malaria in endemic 
areas have identified longer time losses as a result of 
delayed malaria diagnosis, potentially leading to a more 
compromised clinical status of patients requiring longer 
recovery time, and thus, higher care costs [5, 16, 34, 
Fig. 2 Tornado diagram of probabilistic sensitivity analysis (PSA) of the average costs per uncomplicated malaria episode in the DRC. This figure 
explores the effect of key parameters on the average costs per uncomplicated malaria episode in DRC, 2017. The gray bar shows the uncertainty 
interval of the average costs by calculating the uncertainty of all parameters (multi‑way PSA). The coloured bars show the uncertainty interval of the 
average costs by calculating the uncertainty of one individual parameter at time (one‑way PSA)
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38–40]. Furthermore, frequent therapeutic attempts 
occurred at the pre-hospital stage, relying on drugs origi-
nating mainly from the informal sector (e.g., self-medica-
tion, pharmaceutical store agents, street sellers of drugs, 
and traditional healers) that emerged as the first choice 
in malaria care-seeking. In DRC, the informal sector does 
not benefit from the NMCP’s intervention packages (e.g., 
training, diagnosis, treatment) and may be a source of 
poor case management with risks of increased morbidity 
and mortality and even the emergence of drug resistance 
that would further increase costs associated with malaria 
[39, 40]. Hence, strategies aiming to reduce the time lost 
are probably crucial for reducing the disease economic 
burden. In the study population, these strategies should 
specifically target patients living in rural areas, those not 
covered by a health insurance, or those with heavy DW 
who were identified as categories potentially experienc-
ing increased time loss per malaria episode.
Direct costs (45.6% of total costs) paid out of pocket by 
families comprised mostly treatment costs and follow-up 
costs. In DRC, the NMCP intervention package provides 
anti-malarial drugs and malaria tests free of charge for 
all patients reaching healthcare facilities [11, 12]. Though 
this is already a salutary measure for the population, 
healthcare policymakers should be urged to fully subsi-
dize care for malaria as they do for other endemic infec-
tious diseases in the country (e.g., tuberculosis, leprosy, 
VIH) [41]. Otherwise, an intermediate measure would 
be to extend the malaria care support to additional costs 
(e.g., fees for medical consultation). However, conversely 
to the rules in force, it appeared that fees were still 
required from patients in order to access anti-malarial 
drugs (around US$ 3.5 per episode) and malaria diagno-
sis (about US$  0.5 per episode), which are supposed to 
be free of charge. Therefore, efforts for more restrictive 
regulation of pricing and care services to malaria patients 
are needed to standardize and effectively reduce direct 
costs paid by patients on arrival in hospitals.
Previous studies arising from different endemic coun-
tries have reported various estimates of cost-of-illness in 
patients with uncomplicated malaria that are similar or 
even significantly different from current results, rang-
ing from US$  180 in the Peruvian Amazon to US$  4.9 
in Ghana as total costs per episode [15, 33, 34, 42–46]. 
Differences noted between cost estimates can be related 
to applied methodological approaches as well as to 
regions’ related socioeconomic characteristics [33–35]. 
For instance, the indirect costs may substantially differ 
in the same country or between different countries if the 
estimations are based on GDP or minimum wage [34]. 
Malaria-associated indirect costs in the present study 
would have been four times lower if the estimates were 
based on the GDP (~ US$ 1.3 per day per capita) instead 
of the minimum wage (~ US$ 5 per day) [47]. Differences 
noted between cost estimates can also be related to ine-
qualities in the deployment and organization of health 
policies between regions [33–35]. In this study, malaria-
associated costs may thus have been underestimated 
since the collection sites in this study were selected for 
their relative accessibility and locations in areas with 
relatively high access to healthcare facilities and more 
intense activities of the NMCP. It is hence conceivable 
that in areas with more limited access to healthcare facili-
ties, the population may be incurring a heavier malaria 
burden and higher cost-of-illness.
All social EQ-5D-3L dimensions (i.e., mobility, self-
care, usual activities, pain/discomfort, and anxiety/
depression) were moderately or severely impaired in 
about half of the patients with uncomplicated malaria. 
The DW and EQ-5D index score were estimated for 
assessing the magnitude of health loss associated with 
specific health outcomes during uncomplicated malaria. 
The results obtained show that one malaria episode is 
associated with poor self-reported quality of life and 
heavy disutility beside its economic burden. However, the 
overall average DW of 0.36 ± 0.2 noted per patient with 
uncomplicated malaria should be considered with cau-
tion since it cannot be definitively established as being 
specific to the malaria-related health condition and the 
starting point for each individual patient (which is not 
VAS = 100) was unknown. Moreover, the average EQ-5D 
index score of 0.62 ± 0.3 was inferred from Zimbabwean 
health preferences as there are not yet established Con-
golese population norms. A patient with uncomplicated 
malaria who was not benefitting from a health insur-
ance mechanism (896 out of 1080; 82.9%) incurred sub-
stantially higher costs, lower quality of life, and heavier 
disutility while losing more time during illness. Health 
insurance is a social protection measure consisting in a 
mechanism of public or private policies aimed at prevent-
ing, reducing, and eliminating the economic and social 
vulnerabilities to poverty or deprivation resulting from 
disease [13]. In the DRC, only around 7% and 1% of the 
population residing in urban and rural areas, respectively, 
were found to be covered by formal health insurance 
programmes in 2017, mainly from employers (> 75%) 
[13]. Notably, wider proportions of malaria patients 
(4.7% in rural areas and 38.8% in urban areas) benefitted 
from health insurance in the current study. The differ-
ence noted would be due to mechanisms for specifically 
reducing malaria care costs that have been implemented 
by the NMCP in addition to all-disease health insurance 
coverage [11]. However, these coverage levels still require 
further improvement. In addition, the distribution of sub-
jects holding such health insurance policies raised equity 
issues to the detriment of the population living in rural 
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areas, the most economically disadvantaged, female sub-
jects, and those with the lowest education levels. Over-
all, as for all other diseases in the DRC’s health system [9, 
11], this study indicated that malaria health care relies 
heavily on patients’ direct payments despite substan-
tial multilateral aid to the NMCP. The large population 
that is not covered by any health insurance mechanisms 
may incur catastrophic out-of-pocket expenses, espe-
cially when attending the private or informal sector for 
treatment. Care conditions and quality of life of malaria 
patients can thus be negatively affected in those not hold-
ing health insurance policies due to high health care costs 
that may drive the use of less effective care or practices 
and delay diagnosis and treatments [10, 14]. Strategies 
for promoting health insurance and access to malaria 
care services thus turn out to be crucial for reducing the 
disease burden in the country. In addition, patients living 
in rural areas incurred a disproportionally higher socio-
economic burden of uncomplicated malaria compared 
to those residing in urban areas as they lost more time 
due to illness, had limited access to health insurance, and 
accounted for most of the poorest patients. This observa-
tion is more likely to be indicative of the country’s health 
system situation. In fact, decades of non-governance have 
resulted in the collapse of the state and the economy in 
the DRC with, as correlates, a lack of public funding and 
weak national leadership, including within the health 
system [9]. This situation led the health authorities to 
encourage the creation of private for-profit and non-
profit health care service delivery points and their inte-
gration into the health system to supply the government’s 
inability to meet the health needs of the population [9, 
10, 41]. The expansion of the private health sector is most 
pronounced in rural areas where the state’s facilities are 
fewer compared to urban areas. The NMCP thus relies 
heavily on private health care providers for implementing 
the national anti-malarial policies and related activities in 
different rural health districts [10, 11]. This may explain 
why malaria patients living in rural settings almost exclu-
sively sought care in the private sector across this study. 
Furthermore, an inefficient workforce deployment is 
noted in the DRC’s health system with an overabundance 
of human resources for health in urban areas in com-
parison to rural areas where the population have few and 
distant health facilities with less qualified workers, lim-
ited delivery of services, and clinics frequently running 
out of materials [9]. Though integrated into the health 
system’s national supply, these private for-profit clinics 
in reality are widely unregulated and most often provide 
health services of unknown quality, increasing the cost 
of health care to the population and delaying necessary 
hospital referrals [10]. The efficiency and effectiveness 
of health care delivery is consequently affected even for 
freely-accessible health services such as those for care 
of uncomplicated malaria. It is, therefore, not surpris-
ing that the quality of life of patients with uncomplicated 
malaria has been more affected in rural areas. These geo-
graphical and social inequalities have been highlighted 
previously in the Congolese population by the EDS-RDC 
II 2013–2014 and require remedy by adapted social poli-
cies and public health strategies [8]. Similar situations 
have been reported in several African countries including 
Ethiopia and Mozambique [18, 48].
While increased subsidization for the management of 
malaria cases and better access to care services will cer-
tainly help in reducing the direct disease burden upon 
families, more general measures are needed to effec-
tively reduce the cost of malaria for the country over a 
longer-term perspective. These measures include any 
control policy or prevention strategy that can contrib-
ute to reducing the number of cases and hence the 
costs associated with malaria. Therefore, more efforts to 
improve socioeconomic conditions, hygiene, and sani-
tation should be put forward in the country. Likewise, 
health communication efforts should figure prominently 
in strategies for reducing the socioeconomic burden of 
malaria via the increase of knowledge and the promotion 
of good practices against malaria [49]. Unsurprisingly, the 
vast majority of respondents had basic knowledge about 
malaria (route of transmission, mode of prevention, and 
main symptoms) and bed nets available in their respec-
tive households, especially in rural areas. This is probably 
because of intensive campaigns initiated in recent years 
throughout the country by the NMCP and community-
based organizations that have been more pronounced in 
rural settings, likely in recognition of the extra challenges 
faced by patients in these regions with higher malaria 
prevalence [7, 11]. These awareness-raising efforts should 
be continued and even scaled-up in the sector of knowl-
edge and practices that were identified to have additional 
gaps to be filled (e.g., patients evoking wrong transmis-
sion mechanisms, drug prescriptions from the informal 
sector as first choice treatments) in both rural and urban 
settings in this study. As the exposure to malaria is high 
in all settings, campaigns for improving the coverage 
and usage of long-lasting insecticidal bed nets (LLINs) in 
households must also be maintained and even strength-
ened in order to consolidate the performance achieved 
[7, 10, 50].
Limitations
This study had some limitations. First, analyses were 
restricted to expenditures from a patient’s perspective, 
which may underestimate the true cost-of-illness since 
this patient-centered approach does not include costs 
from the health care provider. For instance, expenses 
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covered by the support from the NMCP (e.g., training 
of clinicians, rapid diagnostic tests, and anti-malarial 
drugs) were not included in cost estimates. Second, 
only patients with uncomplicated symptomatic malaria 
were considered. In cases of severe malaria, the disease 
burden is expected to be much heavier than that noted 
here because of potentially higher treatment costs, more 
impaired quality of life, and putative longer duration of 
illness with the possibility of serious or even fatal compli-
cations [14, 15, 22, 23]. Third, the study design was based 
on interviews with respondents in accessible NMCP 
sentinel sites and, therefore, cannot be spared from the 
memory and selection bias that this entails. Fourth, this 
study has provided empirical evidence based on patients 
reaching healthcare facilities who may be different from 
the general population. It is, therefore, difficult to specu-
late on the possible impact that this would have on the 
results noted in this study. The precise income lost due to 
illness would have strengthened the study findings. How-
ever, given the confidentiality requests made by partici-
pants, this important information could not be obtained. 
Cost estimations were consequently based on the mini-
mum wage for economically active individuals, defined 
as those who were ≥ 15 years old. Though this empirical 
estimation is allowed for labour force evaluation [28], it 
may have biased the outcome estimates. Finally, regard-
ing the quality of life, the population norms (i.e., in 
healthy people) and the baseline of patients (i.e., before 
the episode) were not available at the time of this study. 
Therefore, caution should be raised in the interpretation 
of HRQL problems that were noted and which could not 
be specifically due to the current malaria episode.
Conclusions
Despite the above-mentioned limitations, this study 
highlights high cost estimates and emphasizes the con-
siderable burden of uncomplicated malaria in the DRC. 
The outcomes provided will be useful to underscore the 
need for continued support and for soliciting appropri-
ate funding from both government and non-government 
organizations for effective malaria control in the coun-
try. This study used factual information to advocate 
subsidizing the management of uncomplicated malaria 
cases through health insurance mechanisms as a key 
policy able to substantially reduce out-of-pocket costs for 
patients and their families while significantly improving 
the quality of their life. Categories of patients identified 
as associated with increased economic costs of illness in 
this study will be critical for decision-making, priority 
setting, and resource allocation of anti-malarial control 
policies.
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